Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). (Q34439371)

From Wikidata

Revision as of 22:43, 17 December 2018 by Daniel Mietchen (talk | contribs) (‎Created claim: author (P50): Centers for Disease Control and Prevention (Q583725), #quickstatements; batch #6154 by User:Daniel Mietchen)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). (English)

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Centers for Disease Control and Prevention

0 references

author name string

Sara Tomczyk

1

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Nancy M Bennett

2

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Charles Stoecker

3

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Ryan Gierke

4

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Matthew R Moore

5

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Cynthia G Whitney

6

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Stephen Hadler

7

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Tamara Pilishvili

8

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Centers for Disease Control and Prevention (CDC)

9

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

publication date

1 September 2014

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Morbidity and Mortality Weekly Report

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

63

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

37

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

822-825

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5779453

6 July 2018

Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5779453

6 July 2018

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5779453

27 October 2018

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5779453

27 October 2018

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5779453

27 October 2018

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5779453

27 October 2018

The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5779453

9 December 2018

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5779453

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34439371&oldid=813926830"